Sentence Recast for Language Developmental Disorders
Trial Summary
What is the purpose of this trial?
Of the 12 million children in the USA growing up bilingual, about 1 million experience Developmental Language Disorder (DLD), a disorder in language learning and use. Currently there is no guidance for speech language pathologists (SLPs) as to the language of intervention for emergent Spanish-English bilingual children with DLD. This project will examine the relationship between language proficiency and the language of intervention, considering monolingual intervention (Spanish or English) and interleaved Spanish-English intervention with the goal of improving language outcomes and thereby strengthening long-term academic achievement
Will I have to stop taking my current medications?
The trial information does not specify whether participants need to stop taking their current medications.
What data supports the effectiveness of the treatment Sentence Recast for language developmental disorders?
Research shows that conversational recast treatment helps children with language disorders learn grammar more quickly and effectively compared to other methods. Children who frequently repeat correct forms during treatment tend to show better progress, indicating that this approach can be beneficial for improving language skills.12345
Is Sentence Recast therapy safe for humans?
The research articles reviewed do not provide specific safety data for Sentence Recast therapy, but they focus on its effectiveness in improving language skills in children with developmental language disorders. Generally, language interventions like Sentence Recast are considered safe as they involve structured language practice rather than medical or drug-based treatments.45678
How does the Sentence Recast treatment differ from other treatments for language developmental disorders?
Sentence Recast treatment is unique because it uses conversational recasting, where children repeat and correct sentences modeled by a clinician, helping them improve their language skills through practice and self-correction. This approach is different from other treatments as it focuses on spontaneous repetition and structural priming to enhance language development.24789
Eligibility Criteria
This trial is for emergent Spanish-English bilingual children in the USA with Developmental Language Disorder (DLD). It aims to help speech language pathologists decide on the best language of intervention. Specific eligibility criteria are not provided, but typically would include a diagnosis of DLD and being bilingual.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive monolingual or interleaved therapy for 16 hours over 9 weeks, focusing on recast therapy in the dominant language with opportunities to use the non-dominant language.
Follow-up
Participants are monitored for language proficiency and effectiveness of the intervention after treatment.
Treatment Details
Interventions
- Sentence Recast
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Houston
Lead Sponsor
National Institute on Deafness and Other Communication Disorders (NIDCD)
Collaborator
University of Delaware
Collaborator